ALNY β€” ALNYLAM PHARMACEUTICALS INC

Ownership history in FengHe Fund Management Pte. Ltd.  Β·  1 quarter on record

This page tracks every 13F SEC filing in which FengHe Fund Management Pte. Ltd. reported a position in ALNYLAM PHARMACEUTICALS INC (ALNY). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
4.9% (2025 Q4)
πŸ“Š Avg. % of fund
4.9%
πŸ“… First filed
2025 Q4
πŸ“… Last filed
2025 Q4
⏱ Quarters held
1
% of Fund (quarterly)    ALNY price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 1 quarter  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 INITIATED 218,700 β€” β€” 4.90% $87.0M $397.65

🏒 Other funds also holding ALNY

As of 2025 Q4 β€” sorted by position size

Bellevue Group AG 3Y 7Y 3.36% ROSENBLUM SILVERMAN SUTTON S F INC /CA 3Y 7Y 3.05% Orbis Allan Gray Ltd 3Y 7Y 2.7% 683 Capital Management, LLC 3Y 7Y 2.44% Avidity Partners Management LP 3Y 2.41% ORBIMED ADVISORS LLC 3Y 7Y 2.34% Polymer Capital Management (HK) LTD 2.08% Casdin Capital, LLC 3Y 7Y 1.85% Parkman Healthcare Partners LLC 3Y 1.81% Rhenman & Partners Asset Management AB 3Y 7Y 1.7%
← Back to FengHe Fund Management Pte. Ltd. Holdings